Cencora Inc. ($COR) Stock Forecast: Down 2.4% Today

What is Cencora Inc.?

Cencora (COR) is a company that is preparing for its upcoming earnings release. The stock has garnered attention due to the expectation of potential growth in its earnings.

Why is Cencora Inc. going down?

COR stock is down 2.4% on Jul 31, 2025 17:56

• The decline in COR's stock today could be due to profit-taking by investors who were possibly anticipating a positive earnings outcome.
• Comparisons with McKesson (MCK) in the medical sector may have impacted investor sentiment, resulting in a sell-off of COR as it might have shown lower performance compared to its sector so far this year.
• Investors might be reassessing their holdings in COR based on its performance relative to McKesson, potentially influencing the downward trend in the stock.

COR Price Chart

COR Technical Analysis

COR News

Cencora ( COR ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2638782/cencora-cor-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release

Are Medical Stocks Lagging McKesson ( MCK ) This Year?

Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2633569/are-medical-stocks-lagging-mckesson-mck-this-year

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.2% Today

XRP ($XRP) Crypto Forecast: Down 5.1% Today

Cardano ($ADA) Crypto Forecast: Down 5.1% Today

Chainlink ($LINK) Crypto Forecast: Down 5.4% Today

Lithia Motors Inc. ($LAD) Stock Forecast: Up 5.1% Today

ONEOK Inc. ($OKE) Stock Forecast: Down 5.0% Today

Transdigm Group Incorporated Inc. ($TDG) Stock Forecast: Down 12.7% Today

Eaton Corporation PLC ($ETN) Stock Forecast: Down 6.7% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 7.2% Today

Pfizer Inc. ($PFE) Stock Forecast: Up 5.0% Today

Cencora Inc. Price History

06.10.2024 - COR Stock was up 5.1%

• In the fourth quarter of 2024, COR exceeded sales expectations, seeing a significant revenue increase in both U.S. and International Healthcare Solutions segments.
• Despite a year-over-year decline in margins, COR's overall Q4 performance was impressive, resulting in an increased dividend and positive market sentiment.
• Analysts were optimistic about COR's earnings and revenue estimates, suggesting potential for ongoing stock growth.
• The market responded positively to COR's better-than-expected Q4 earnings and revenue, propelling the bullish movement in the stock price.

03.00.2025 - COR Stock was up 3.4%

• Market expectations point towards a potential increase in COR stock, reflecting optimistic investor sentiment.
• COR has outperformed the market by 4.82% annually over the last decade, highlighting its robust historical performance.
• Today's positive uptick in COR may be linked to the favorable outlook in the options market and its consistent market outperformance.

15.09.2024 - COR Stock was up 2.3%

• COR experienced a strong bullish movement recently, possibly due to investor optimism and confidence in the company's financial performance.
• Expectations of COR surpassing earnings estimates in the near future may have influenced the positive market sentiment.
• The consistent outperformance of COR compared to the market could have attracted more investors, boosting the stock price.
• In summary, COR's solid historical performance, anticipated positive earnings, and market outperformance likely drove the recent bullish movement in the stock.

08.04.2025 - COR Stock was down 4.2%

• Despite surpassing Q2 earnings and revenue estimates, COR witnessed a bearish movement in the market.
• Concerns about revenue sustainability and competition in the pharmaceutical sector may have contributed to the market's negative reaction.
• Investor caution regarding the company's growth sustainability could result in profit-taking and a bearish stock price trend.
• Broader economic factors and sector-specific challenges in the pharmaceutical industry might also influence the market movement.

08.04.2025 - COR Stock was down 5.2%

• Despite surpassing Q2 earnings and revenue expectations, COR observed a decline in its stock price today.
• The high demand for weight loss drugs and specialty products might not have sustained the stock's elevated value, resulting in profit-taking by traders.
• The market's response could be due to concerns regarding future growth prospects or uncertainties about the company's trajectory.
• Investors may have anticipated stronger results or guidance from COR, triggering a stock sell-off despite its recent accomplishments in the healthcare solutions industry.

15.09.2024 - COR Stock was up 5.7%

• Cencora's stock price surged today as investors continue to be impressed by its consistent outperformance compared to the market over the past 5 years.
• The significant growth of $1000 invested in Cencora 5 years ago to $2,700 today likely attracted more investors to the stock, driving up demand.
• The market capitalization of $43.54 billion indicates strong investor confidence in Cencora's future growth prospects, further fueling today's bullish movement.
• Overall, Cencora's impressive track record and positive market sentiment seem to have contributed to today's strong bullish performance.

05.01.2025 - COR Stock was down 0.3%

• The bearish movement in COR stock today could be attributed to profit-taking by investors despite the company surpassing Q1 earnings and revenue estimates.
• The strong performance in the U.S. Healthcare Solutions segment might have been already priced in, leading to a sell-off.
• The stiff competition could be causing concerns among investors, leading to the bearish trend.
• The stock's historical outperformance and market capitalization may have set high expectations, and any deviation from this trajectory could trigger a negative market reaction.

07.04.2025 - COR Stock was up 5.7%

• COR outperformed Q2 earnings and revenue expectations, signaling robust financial results.
• The U.S. Healthcare Solutions segment's favorable outlook is anticipated to be a key driver of COR's success.
• Analysts hold a positive view on COR's crucial metrics for the quarter, indicating a favorable path for the company.
• Investors reacted favorably to the strong performance and growth potential of COR, leading to the uptrend in the stock price.

28.02.2024 - COR Stock was down 0.9%

• The bearish movement in COR stock today could be attributed to investors' concerns about the stiff competition in the U.S. Healthcare Solutions segment.
• Despite the company gaining traction in the industry, the competitive landscape might be causing uncertainty among investors, leading to a sell-off of the stock.
• Investors may be reevaluating the growth potential of COR amidst the challenges posed by its competitors, resulting in the bearish market movement today.

27.05.2024 - COR Stock was down 5.1%

• The recent decline in COR stock may be due to:
• Competition in the healthcare solutions sector impacting the company's growth outlook.
• Investor doubts about the company's competitive position despite its potential.
• Changes in market sentiment, potentially influenced by profit-taking or broader market conditions, contributing to the stock's downward trend.

04.03.2025 - COR Stock was down 0.7%

• Despite being considered a safe bet during market volatility, COR faced a strong bearish movement today.
• The comparison with other medical stocks like Intensity Therapeutics Inc. may have highlighted weaknesses in COR's performance, contributing to the bearish trend.
• The overall market volatility, potentially influenced by external factors, could have also played a role in the bearish movement of COR today.

31.06.2025 - COR Stock was down 2.4%

• The decline in COR's stock today could be due to profit-taking by investors who were possibly anticipating a positive earnings outcome.
• Comparisons with McKesson (MCK) in the medical sector may have impacted investor sentiment, resulting in a sell-off of COR as it might have shown lower performance compared to its sector so far this year.
• Investors might be reassessing their holdings in COR based on its performance relative to McKesson, potentially influencing the downward trend in the stock.